Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T5TU
|
||||
Former ID |
DIB004295
|
||||
Drug Name |
TPI-1020
|
||||
Synonyms |
Nitrobudesonide; NCX-1020; NO-budesonide; Budesonide-21-nitrooxymethylbenzoate
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Phase 2 | [522042] | ||
Company |
NicOx SA
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1=C[C@]2(C(=CC1=O)CC[C@@H]1[C@@H]2[C@H](C[C@]2([C@H]1C<br />[C@@H]1[C@]2(OC(O1)CCC)C(=O)COC(=O)c1ccc(cc1)CO[N+](=O)<br />[O-])C)O)C
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Antagonist | [531896] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.